Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: Primary results from the phase III MARIANNE study

  1. Perez, E.A.
  2. Barrios, C.
  3. Eiermann, W.
  4. Toi, M.
  5. Im, Y.-H.
  6. Conte, P.
  7. Martin, M.
  8. Pienkowski, T.
  9. Pivot, X.
  10. Burris, H.
  11. Petersen, J.A.
  12. Stanze, S.
  13. Strasak, A.
  14. Patre, M.
  15. Ellis, P.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2017

Alea: 35

Zenbakia: 2

Orrialdeak: 141-148

Mota: Artikulua

DOI: 10.1200/JCO.2016.67.4887 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus